SLC2A1 and Alzheimer disease: Liraglutide treatment did not significantly affect brain GLUT1 and GLUT4 (an insulin-sensitive glucose transporter; F(2,13) = 4.491, p = 0.033) or glucose content in early AD-like female mice compared to 3xTg-AD female mice (Figure 4A–C).